Navigation Links
New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging

Women Report Partner's Symptoms Negatively Affect Relationship

BOCA RATON, Fla., June 25, 2007 /PRNewswire/ -- Results of a new nationwide survey show that more than half of women whose male partners have symptoms of a medical condition known as low testosterone incorrectly attribute them to the normal course of aging. The survey also found that, while women believe their male partner's symptoms of low testosterone negatively impact their relationship, treatment of the condition improves the quality of the relationship.

Low testosterone, or testosterone deficiency associated with hypogonadism, is a medical condition caused by disease or damage to the testicles, hypothalamus, or pituitary gland that inhibits hormone secretion and testosterone production in men. As many as five million men over the age of 18 have lower than normal levels of testosterone.(1)

"Most people don't realize that low testosterone is a serious medical condition, and one that can have an impact on the entire family," said Tanya Abreu, President and National Program Director, Spirit of Women Health Network, which commissioned the survey. "If left untreated, low testosterone can affect a man's overall health, personal relationships, and quality of life. And, it can also affect his partner's perception of the relationship and quality of life. At Spirit of Women, we believe health is quality of life."

As reported by the women surveyed, symptoms of low testosterone in most symptomatic men included lack of energy (64%), decreased libido (61%), less strong erections (64%), a sad and/ or grumpy mood (58%), and irritability (60%). Symptoms most troublesome to women with a symptomatic partner are mood swings (91%), depression (91%), irritability (86%), a sad and/ or grumpy mood (81%), and decreased enjoyment of life (74%).

The online survey of 2,008 women aged 30 or older (mean age 45.8 years) in a romantic relationship f or at least three years (mean 19.8 years) with a man aged 35 to 65 (mean age 48.8 years) was conducted by Harris Interactive on behalf of Spirit of Women, a national coalition that inspires health and wellness for women and their families on a local level by leveraging national resources.

Scientific research links decreased levels of testosterone in men to a number of significant medical conditions, including metabolic syndrome, insulin resistance, Type 2 diabetes, abnormal blood lipids, cardiovascular disease and osteoporosis.(2) The most recent research, conducted by the University of California at San Diego, found low testosterone may lead to a greater risk of death in men aged 50 and older. The study tracked nearly 800 men, 50 to 91 years old, living in California and found that men with low testosterone had a 33 percent greater death risk over their next 18 years of life compared with men who had higher testosterone.

    Other Key Survey Findings

    The survey also found:

    -- Among women with symptomatic partners, 44% of those whose partners have

       not visited his doctor predict that the barrier to visiting is that he

       thinks his symptoms are a normal part of aging.

    -- Among women with symptomatic partners, 18% have not discussed their

       partner's symptoms and 28% report that they are not comfortable

       discussing his symptoms.

    The Symptoms of Low T Negatively Affect Relationship Quality

    -- Women with symptomatic (27%) or diagnosed (48%) partners indicate that

       the symptoms of low T affect/ affected their relationship.

    -- Less physical intimacy is mentioned by women with symptomatic partners

       (72%) and women with diagnosed partners (78%) as the largest impact

       symptoms have or had on their relationship.

    -- Women with symptomatic partners also report that communication with

       their partner suffers (51%) and that they feel more lonely (47%).

    -- Two-thirds of w
omen whose partners have been diagnosed mention that

       prior to his diagnosis, their partner seemed distant.

    Treating Low T Improves Relationship Quality

    -- Forty-two percent of women with a diagnosed partner report that his

       treatment (most often testosterone replacement therapy) improved their

       partner's symptoms.

    -- One-third of women with a diagnosed partner indicate that their quality

       of life has improved as a result of their partner's treatment for low


    -- Prior to diagnosis, just over half (57%) of women were satisfied with

       the quality of their relationship.  After their partner was diagnosed

       with low T, 81 percent of women are satisfied with the quality of their

       current relationship.

About Hypogonadism (Low Testosterone)

Physical signs of hypogonadism can include incomplete sexual development, body hair loss, reduced muscle bulk and increased body fat, height loss, low bone density and impaired sperm production. Symptoms associated with hypogonadism can include reduced sexual desire, depression, changes in mood, poor concentration, decreased energy and motivation, and increased sleepiness.

Men who believe they may be suffering from low testosterone should talk to their doctors about the Androgen Deficiency in Aging Men (ADAM) questionnaire. The ADAM questionnaire consists of 10 simple questions that will help the doctor determine if the patient has hypogonadism. A blood test can confirm hypogonadism by measuring testosterone levels. The doctor will then determine if the patient is a candidate for testosterone replacement therapy and, if so, which treatment options are right for him.

About the Survey Methodology

This online survey was conducted between May 29 and June 4, 2007 within the United States by Harris Interactive(R) on behalf of Spirit of Women with funding provided by Auxilium Pharmaceuticals, Inc. An adapted version of the ADAM questionnaire was used to classify women into one of three groups: diagnosed partner (N=43); symptomatic partner (N=968); non-symptomatic partner (N=997).

Harris Interactive recruited the survey respondents via email through the HarrisPollOnline (HPOL). Figures for age by sex, race/ethnicity, education, region and household income were weighted where necessary to bring them into line with their actual proportions in the population. Propensity score weighting was also used to adjust for respondents' propensity to be online. This methodology helps to ensure that results are nationally representative.

With a pure probability sample of 2,008 one could say with a 95 percent probability that the overall results would have a sampling error of +/- 2.2 percentage points. This online survey is not based on a probability sample and therefore no theoretical sampling error can be calculated.

About Spirit of Women

Spirit of Women is a national network of leading hospitals dedicated to improving women's lives with innovative health and community programs. Spirit of Women Hospitals touch the lives of millions of women each year through the presentation of educational events, consumer membership programs, annual conferences, marketing communications and grass roots efforts to improve the health and well-being of women everywhere. The initiative enables participating hospitals to focus on community needs while providing the strength of national support. Please visit for additional information.

    Contact: Tara DiMilia, 908-369-7168

    (1)  FDA website -

    (2)  The Endocrine Society's Clinical Guidelines: Testosterone Therapy in

         Adult Men with Androgen Deficiency Syndrome:

         An Endocrine Society Clinical Practice Guideline
; J Cli. End & Metab.


CONTACT: Tara DiMilia for Spirit of Women, +1-908-369-7168

Web site:

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
Post Your Comments:
(Date:10/12/2017)... Oct. 12, 2017   Divoti USA will ... to the standard of the latest FDA requirements, which stipulates new ... Anyone in need of Medical ID jewelry such as Medical ... are engraved in terms of the new FDA requirements ... Divoti offers this dark ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):